Jeffrey J. Legos

4.5k total citations
29 papers, 1.7k citations indexed

About

Jeffrey J. Legos is a scholar working on Molecular Biology, Neurology and Pathology and Forensic Medicine. According to data from OpenAlex, Jeffrey J. Legos has authored 29 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 7 papers in Neurology and 5 papers in Pathology and Forensic Medicine. Recurrent topics in Jeffrey J. Legos's work include Melanoma and MAPK Pathways (8 papers), Spinal Cord Injury Research (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Jeffrey J. Legos is often cited by papers focused on Melanoma and MAPK Pathways (8 papers), Spinal Cord Injury Research (4 papers) and Neuroinflammation and Neurodegeneration Mechanisms (4 papers). Jeffrey J. Legos collaborates with scholars based in United States, United Kingdom and France. Jeffrey J. Legos's co-authors include Frank C. Barone, Joseph A. Erhardt, Andrew A. Parsons, Ronald F. Tuma, Ray F. White, Elias Aizenman, BethAnn McLaughlin, Karen A. Hartnett, Elaine Irving and A. Jacqueline Hunter and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Brain Research and Clinical Cancer Research.

In The Last Decade

Jeffrey J. Legos

28 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jeffrey J. Legos United States 20 836 408 404 256 229 29 1.7k
Kazuhiro Imamura Japan 15 546 0.7× 483 1.2× 316 0.8× 227 0.9× 257 1.1× 47 1.5k
Didier Divoux France 23 868 1.0× 754 1.8× 386 1.0× 251 1.0× 327 1.4× 31 2.7k
Heike Beck Germany 22 1.7k 2.0× 566 1.4× 502 1.2× 170 0.7× 206 0.9× 37 2.9k
Shao-Hua Yang United States 26 855 1.0× 378 0.9× 340 0.8× 128 0.5× 506 2.2× 35 2.3k
Takashi Otsuka Japan 21 972 1.2× 275 0.7× 248 0.6× 428 1.7× 289 1.3× 65 2.3k
Chunhua Chen China 25 688 0.8× 384 0.9× 235 0.6× 144 0.6× 174 0.8× 78 1.8k
Cecylia Zaloga United States 9 874 1.0× 654 1.6× 472 1.2× 130 0.5× 351 1.5× 9 1.9k
Noriaki Mitsuda Japan 19 1.0k 1.2× 222 0.5× 432 1.1× 140 0.5× 382 1.7× 50 1.8k
Yang Tang China 25 1.2k 1.4× 296 0.7× 204 0.5× 340 1.3× 182 0.8× 57 2.2k
Minoru Seto Japan 27 1.5k 1.8× 249 0.6× 366 0.9× 139 0.5× 666 2.9× 53 2.8k

Countries citing papers authored by Jeffrey J. Legos

Since Specialization
Citations

This map shows the geographic impact of Jeffrey J. Legos's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey J. Legos with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey J. Legos more than expected).

Fields of papers citing papers by Jeffrey J. Legos

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey J. Legos. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey J. Legos. The network helps show where Jeffrey J. Legos may publish in the future.

Co-authorship network of co-authors of Jeffrey J. Legos

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey J. Legos. A scholar is included among the top collaborators of Jeffrey J. Legos based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey J. Legos. Jeffrey J. Legos is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hauschild, Axel, Mario Santinami, Georgina V. Long, et al.. (2017). COMBI-AD: Adjuvant dabrafenib (D) plus trametinib (T) for resected stage III BRAF V600E/K–mutant melanoma. Annals of Oncology. 28. v631–v631. 3 indexed citations
2.
Santiago-Walker, Ademi, Robert Gagnon, Jolly Mazumdar, et al.. (2015). Correlation of BRAF Mutation Status in Circulating-Free DNA and Tumor and Association with Clinical Outcome across Four BRAFi and MEKi Clinical Trials. Clinical Cancer Research. 22(3). 567–574. 158 indexed citations
3.
4.
Hansen, Michael K., Matthew J. McVey, Ray F. White, et al.. (2010). Selective CETP Inhibition and PPARα Agonism Increase HDL Cholesterol and Reduce LDL Cholesterol in Human ApoB100/Human CETP Transgenic Mice. Journal of Cardiovascular Pharmacology and Therapeutics. 15(2). 196–202. 16 indexed citations
5.
Legos, Jeffrey J., Stephen C. Lenhard, Thomas Schaeffer, et al.. (2008). SB 234551 selective ETA receptor antagonism: Perfusion/Diffusion MRI used to define treatable stroke model, time to treatment and mechanism of protection. Experimental Neurology. 212(1). 53–62. 35 indexed citations
6.
Barone, Frank C., Matthew E. Barton, Ray F. White, et al.. (2007). Inhibition of Phosphodiesterase Type 4 Decreases Stress-Induced Defecation in Rats and Mice. Pharmacology. 81(1). 11–17. 20 indexed citations
7.
Jucker, Beat M., Dewen Yang, Warren Casey, et al.. (2007). Selective PPARδ agonist treatment increases skeletal muscle lipid metabolism without altering mitochondrial energy coupling: an in vivo magnetic resonance spectroscopy study. American Journal of Physiology-Endocrinology and Metabolism. 293(5). E1256–E1264. 22 indexed citations
8.
Weaver, Michael, et al.. (2002). LEX032, A Novel Recombinant Serpin, Protects the Brain after Transient Focal Ischemia. Microvascular Research. 63(3). 327–334. 10 indexed citations
9.
Hay, Douglas W.P., Giuseppe Giardina, Don E. Griswold, et al.. (2002). Nonpeptide Tachykinin Receptor Antagonists. III. SB 235375, a Low Central Nervous System-Penetrant, Potent and Selective Neurokinin-3 Receptor Antagonist, Inhibits Citric Acid-Induced Cough and Airways Hyper-reactivity in Guinea Pigs. Journal of Pharmacology and Experimental Therapeutics. 300(1). 314–323. 75 indexed citations
10.
Legos, Jeffrey J., BethAnn McLaughlin, Stephen D. Skaper, et al.. (2002). The selective p38 inhibitor SB-239063 protects primary neurons from mild to moderate excitotoxic injury. European Journal of Pharmacology. 447(1). 37–42. 54 indexed citations
11.
Tuma, Ronald F., Jeffrey J. Legos, & Frank C. Barone. (2002). Pharmacological interventions for stroke: failures and future. Expert Opinion on Investigational Drugs. 11(5). 603–614. 52 indexed citations
12.
Young, William F., et al.. (2002). Non-surgical management of spinal cord injury. Expert Opinion on Investigational Drugs. 11(4). 469–482. 7 indexed citations
13.
Legos, Jeffrey J., Arduino A. Mangoni, Simon Read, et al.. (2002). Programmable microchip monitoring of post-stroke pyrexia: effects of aspirin and paracetamol on temperature and infarct size in the rat. Journal of Neuroscience Methods. 113(2). 159–166. 17 indexed citations
14.
Legos, Jeffrey J., Joseph A. Erhardt, Raymond F. White, et al.. (2001). SB 239063, a novel p38 inhibitor, attenuates early neuronal injury following ischemia. Brain Research. 892(1). 70–77. 90 indexed citations
15.
Legos, Jeffrey J., et al.. (2001). Tonicity of Resuscitative Fluids Influences Outcome after Spinal Cord Injury. Neurosurgery. 48(1). 167–173.
16.
Legos, Jeffrey J., et al.. (2001). Tonicity of Resuscitative Fluids Influences Outcome after Spinal Cord Injury. Neurosurgery. 48(1). 167–173. 14 indexed citations
17.
18.
Erhardt, Joseph A., Jeffrey J. Legos, Roy A. Johanson, J. Randall Slemmon, & Xinkang Wang. (2000). Expression of PEP-19 inhibits apoptosis in PC12 cells. Neuroreport. 11(17). 3719–3723. 47 indexed citations
19.
Legos, Jeffrey J., Robert G. Whitmore, Joseph A. Erhardt, et al.. (2000). Quantitative changes in interleukin proteins following focal stroke in the rat. Neuroscience Letters. 282(3). 189–192. 78 indexed citations
20.
Braverman, Alan S., Jeffrey J. Legos, William J. Young, G R Luthin, & Michael R. Ruggieri. (1999). M2 receptors in genito-urinary smooth muscle pathology. Life Sciences. 64(6-7). 429–436. 66 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kazuhiro Imamura Breakdown of academic impact, for papers by Didier Divoux Breakdown of academic impact, for papers by Heike Beck Breakdown of academic impact, for papers by Shao-Hua Yang Breakdown of academic impact, for papers by Takashi Otsuka Breakdown of academic impact, for papers by Chunhua Chen Breakdown of academic impact, for papers by Cecylia Zaloga Breakdown of academic impact, for papers by Noriaki Mitsuda Breakdown of academic impact, for papers by Yang Tang Breakdown of academic impact, for papers by Minoru Seto
Rankless by CCL
2026